Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H12O3 |
| Molecular Weight | 228.2433 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(C(=O)C2=CC=CC=C2)C(O)=C1
InChI
InChIKey=DXGLGDHPHMLXJC-UHFFFAOYSA-N
InChI=1S/C14H12O3/c1-17-11-7-8-12(13(15)9-11)14(16)10-5-3-2-4-6-10/h2-9,15H,1H3
DescriptionSources: http://www.thedermreview.com/oxybenzone/
Sources: http://www.thedermreview.com/oxybenzone/
Oxybenzone is one of the more popular molecules used by chemists during the manufacturing of cosmetics and is included in sunscreen for UV protection. The chemical is often used to stabilize and strengthen the color and scent of skin care products, but its widest use is in the form of sun block. Unfortunately, the debate about the safety of oxybenzone is still ongoing. One of the biggest concerns in the medical community about the widespread use of the molecule comes from the fact that it’s easily absorbed into the body. This absorption raises concerns that oxybenzone may accumulate in the body, eventually leading to potentially toxic levels of the chemical, which can affect the endocrine system.
Originator
Approval Year
Cmax
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
94.2 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31961417/ |
2 mg/cm² single, topical dose: 2 mg/cm² route of administration: Topical experiment type: SINGLE co-administered: AVOBENZONE |
OXYBENZONE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
258.1 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31961417/ |
2 mg/cm² 4 times / day multiple, topical dose: 2 mg/cm² route of administration: Topical experiment type: MULTIPLE co-administered: AVOBENZONE |
OXYBENZONE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
85.4 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31961417/ |
2 mg/cm² single, topical dose: 2 mg/cm² route of administration: Topical experiment type: SINGLE co-administered: AVOBENZONE |
OXYBENZONE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
180.1 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31961417/ |
2 mg/cm² 4 times / day multiple, topical dose: 2 mg/cm² route of administration: Topical experiment type: MULTIPLE co-administered: |
OXYBENZONE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
AUC
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
1204 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31961417/ |
2 mg/cm² single, topical dose: 2 mg/cm² route of administration: Topical experiment type: SINGLE co-administered: AVOBENZONE |
OXYBENZONE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
3443.7 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31961417/ |
2 mg/cm² 4 times / day multiple, topical dose: 2 mg/cm² route of administration: Topical experiment type: MULTIPLE co-administered: AVOBENZONE |
OXYBENZONE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
1159.6 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31961417/ |
2 mg/cm² single, topical dose: 2 mg/cm² route of administration: Topical experiment type: SINGLE co-administered: AVOBENZONE |
OXYBENZONE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
2757.3 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31961417/ |
2 mg/cm² 4 times / day multiple, topical dose: 2 mg/cm² route of administration: Topical experiment type: MULTIPLE co-administered: |
OXYBENZONE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
78.5 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31961417/ |
2 mg/cm² single, topical dose: 2 mg/cm² route of administration: Topical experiment type: SINGLE co-administered: AVOBENZONE |
OXYBENZONE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
79.2 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31961417/ |
2 mg/cm² single, topical dose: 2 mg/cm² route of administration: Topical experiment type: SINGLE co-administered: AVOBENZONE |
OXYBENZONE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
Doses
| Dose | Population | Adverse events |
|---|---|---|
10 % single, topical Accidental dose |
unknown |
Other AEs: Eczema... |
6 % 4 times / day multiple, topical Recommended Dose: 6 %, 4 times / day Route: topical Route: multiple Dose: 6 %, 4 times / day Sources: |
unknown Health Status: unknown Sex: M+F Food Status: UNKNOWN Sources: |
Other AEs: Rash... |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Eczema | 10 % single, topical Accidental dose |
unknown |
|
| Rash | 16.7% | 6 % 4 times / day multiple, topical Recommended Dose: 6 %, 4 times / day Route: topical Route: multiple Dose: 6 %, 4 times / day Sources: |
unknown Health Status: unknown Sex: M+F Food Status: UNKNOWN Sources: |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Quantification of organic eluates from polymerized resin-based dental restorative materials by use of GC/MS. | 2007-05-01 |
|
| Determination of UV filters and antimicrobial agents in environmental water samples. | 2007-02 |
|
| Expression of osteoblast marker genes in rat calvarial osteoblast-like cells, and effects of the endocrine disrupters diphenylolpropane, benzophenone-3, resveratrol and silymarin. | 2006-12-15 |
|
| Parabens as urinary biomarkers of exposure in humans. | 2006-12 |
|
| Endocrine disruptors and rat adrenocortical function: studies on freshly dispersed and cultured cells. | 2006-12 |
|
| A validated method for the determination of traces of UV filters in fish using LC-MS/MS. | 2006-11 |
|
| Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods. | 2006-11 |
|
| Simultaneous determination of benzophenone-type UV filters in water and soil by gas chromatography-mass spectrometry. | 2006-10-27 |
|
| Sunscreen enhancement of UV-induced reactive oxygen species in the skin. | 2006-10-15 |
|
| Photopatch testing of 1155 patients: results of the U.K. multicentre photopatch study group. | 2006-10 |
|
| Estradiol and resveratrol stimulating effect on osteocalcin, but not osteonectin and collagen-1alpha gene expression in primary culture of rat calvarial osteoblast-like cells. | 2006-10 |
|
| Preparation and characterization of oxybenzone-loaded gelatin microspheres for enhancement of sunscreening efficacy. | 2006-08-01 |
|
| Causal agents of photoallergic contact dermatitis diagnosed in the national institute of dermatology of Colombia. | 2006-08 |
|
| Photoallergic contact cheilitis due to oxybenzone found in a lip cosmetic. | 2006-07 |
|
| Activity related to the carcinogenicity of plastic additives in the benzophenone group. | 2006-06-01 |
|
| Bioactive constituents from Chinese natural medicines. XVII. constituents with radical scavenging effect and new glucosyloxybenzyl 2-isobutylmalates from Gymnadenia conopsea. | 2006-04 |
|
| Estrogenic activities of chemicals related to food contact plastics and rubbers tested by the yeast two-hybrid assay. | 2006-04 |
|
| Comparison of in vitro and in vivo estrogenic activity of UV filters in fish. | 2006-04 |
|
| In vitro permeation of repellent DEET and sunscreen oxybenzone across three artificial membranes. | 2006-03-09 |
|
| Photocontact allergy to oxybenzone and contact allergy to lignocaine and prilocaine. | 2006-03 |
|
| Photoallergic contact dermatitis from ketoprofen in southern Sweden. | 2006-03 |
|
| Percutaneous absorption of the sunscreen benzophenone-3 after repeated whole-body applications, with and without ultraviolet irradiation. | 2006-02 |
|
| Evaluation of the photostability of different UV filter combinations in a sunscreen. | 2006-01-13 |
|
| Influence of complexation with cyclodextrins on photo-induced free radical production by the common sunscreen agents octyl-dimethylaminobenzoate and octyl-methoxycinnamate. | 2006-01 |
|
| In vivo bioassay-guided fractionation of marine sediment extracts from the Southern California Bight, USA, for estrogenic activity. | 2005-11 |
|
| Separation via flotation, spectrophotometric speciation, and determination of vanadium(IV) in wastes of power stations. | 2005-11 |
|
| Additive estrogenic effects of mixtures of frequently used UV filters on pS2-gene transcription in MCF-7 cells. | 2005-10-15 |
|
| Quantification of urinary conjugates of bisphenol A, 2,5-dichlorophenol, and 2-hydroxy-4-methoxybenzophenone in humans by online solid phase extraction-high performance liquid chromatography-tandem mass spectrometry. | 2005-10 |
|
| Photoallergic and allergic reaction to 2-hydroxy-4-methoxybenzophenone (sunscreen) and allergy to cetyl alcohol in cosmetic cream. | 2005-09 |
|
| Screening for androgen receptor activities in 253 industrial chemicals by in vitro reporter gene assays using AR-EcoScreen cells. | 2005-09 |
|
| Fading of artificial hair color and its prevention by photofilters. | 2005-08-09 |
|
| Simultaneous analysis of insect repellent DEET, sunscreen oxybenzone and five relevant metabolites by reversed-phase HPLC with UV detection: application to an in vivo study in a piglet model. | 2005-08-05 |
|
| [Estrogenic activity of ultraviolet absorbers and the related compounds]. | 2005-08 |
|
| Assay of common sunscreen agents in suncare products by high-performance liquid chromatography on a cyanopropyl-bonded silica column. | 2005-06-15 |
|
| The effect of packaging materials on the stability of sunscreen emulsions. | 2005-06-13 |
|
| In vitro evaluation of concurrent use of commercially available insect repellent and sunscreen preparations. | 2005-06 |
|
| Estrogenic activity of cosmetic components in reporter cell lines: parabens, UV screens, and musks. | 2005-02-27 |
|
| Occurrence of some organic UV filters in wastewater, in surface waters, and in fish from Swiss Lakes. | 2005-02-15 |
|
| Interaction of polycyclic musks and UV filters with the estrogen receptor (ER), androgen receptor (AR), and progesterone receptor (PR) in reporter gene bioassays. | 2005-02 |
|
| Sunscreens - which and what for? | 2004-12-13 |
|
| Effects of estradiol, benzophenone-2 and benzophenone-3 on the expression pattern of the estrogen receptors (ER) alpha and beta, the estrogen receptor-related receptor 1 (ERR1) and the aryl hydrocarbon receptor (AhR) in adult ovariectomized rats. | 2004-12-01 |
|
| Unexpected photolysis of the sunscreen octinoxate in the presence of the sunscreen avobenzone. | 2004-11-25 |
|
| Sunscreen penetration of human skin and related keratinocyte toxicity after topical application. | 2004-09-28 |
|
| Recrystallization in different sunscreen formulations after cutaneous application. | 2004-07 |
|
| Systemic absorption of the sunscreens benzophenone-3, octyl-methoxycinnamate, and 3-(4-methyl-benzylidene) camphor after whole-body topical application and reproductive hormone levels in humans. | 2004-07 |
|
| [First derivative spetrophotometric direct determination of 2-hydroxy-4-methoxybenzo phenone in polyester resin by computer assistant]. | 2004-06 |
|
| In-vitro permeation of the insect repellent N,N-diethyl-m-toluamide (DEET) and the sunscreen oxybenzone. | 2004-05 |
|
| Occurrence of UV filter compounds from sunscreens in surface waters: regional mass balance in two Swiss lakes. | 2004-05 |
|
| Liquid chromatographic assay for common sunscreen agents: application to in vivo assessment of skin penetration and systemic absorption in human volunteers. | 2004-04-25 |
|
| Contact and photocontact allergy to ketoprofen. The Belgian experience. | 2004-04 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 352.10
Created by
admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
|
||
|
EPA PESTICIDE CODE |
691
Created by
admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
|
||
|
CFR |
21 CFR 352.20
Created by
admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
|
||
|
FDA ORPHAN DRUG |
142401
Created by
admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
|
||
|
NCI_THESAURUS |
C851
Created by
admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
OXYBENZONE
Created by
admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
|
PRIMARY | |||
|
32673
Created by
admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
|
PRIMARY | RxNorm | ||
|
CHEMBL1625
Created by
admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
|
PRIMARY | |||
|
2096
Created by
admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
|
PRIMARY | |||
|
3412
Created by
admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
|
PRIMARY | |||
|
100000083280
Created by
admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
|
PRIMARY | |||
|
131-57-7
Created by
admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
|
PRIMARY | |||
|
DTXSID3022405
Created by
admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
|
PRIMARY | |||
|
7778
Created by
admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
|
PRIMARY | |||
|
SUB09556MIG
Created by
admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
|
PRIMARY | |||
|
DB01428
Created by
admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
|
PRIMARY | |||
|
1485001
Created by
admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
|
PRIMARY | |||
|
C47646
Created by
admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
|
PRIMARY | |||
|
34283
Created by
admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
|
PRIMARY | |||
|
4503
Created by
admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
|
PRIMARY | |||
|
4632
Created by
admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
|
PRIMARY | |||
|
205-031-5
Created by
admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
|
PRIMARY | |||
|
95OOS7VE0Y
Created by
admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
|
PRIMARY | |||
|
95OOS7VE0Y
Created by
admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
|
PRIMARY | |||
|
C005290
Created by
admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
|
PRIMARY | |||
|
m8323
Created by
admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
|
PRIMARY | Merck Index |
ACTIVE MOIETY